These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 21245488)
1. AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein. Steffen B; Knop M; Bergholz U; Vakhrusheva O; Rode M; Köhler G; Henrichs MP; Bulk E; Hehn S; Stehling M; Dugas M; Bäumer N; Tschanter P; Brandts C; Koschmieder S; Berdel WE; Serve H; Stocking C; Müller-Tidow C Blood; 2011 Apr; 117(16):4328-37. PubMed ID: 21245488 [TBL] [Abstract][Full Text] [Related]
2. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077 [TBL] [Abstract][Full Text] [Related]
3. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Okuda T; Cai Z; Yang S; Lenny N; Lyu CJ; van Deursen JM; Harada H; Downing JR Blood; 1998 May; 91(9):3134-43. PubMed ID: 9558367 [TBL] [Abstract][Full Text] [Related]
4. Definition of a small core transcriptional circuit regulated by AML1-ETO. Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982 [TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. de Guzman CG; Warren AJ; Zhang Z; Gartland L; Erickson P; Drabkin H; Hiebert SW; Klug CA Mol Cell Biol; 2002 Aug; 22(15):5506-17. PubMed ID: 12101243 [TBL] [Abstract][Full Text] [Related]
7. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation. Bäsecke J; Schwieger M; Griesinger F; Schiedlmeier B; Wulf G; Trümper L; Stocking C Leuk Lymphoma; 2005 Feb; 46(2):265-72. PubMed ID: 15621811 [TBL] [Abstract][Full Text] [Related]
8. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Mulloy JC; Cammenga J; MacKenzie KL; Berguido FJ; Moore MA; Nimer SD Blood; 2002 Jan; 99(1):15-23. PubMed ID: 11756147 [TBL] [Abstract][Full Text] [Related]
9. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455 [TBL] [Abstract][Full Text] [Related]
10. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465 [TBL] [Abstract][Full Text] [Related]
11. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. Schessl C; Rawat VP; Cusan M; Deshpande A; Kohl TM; Rosten PM; Spiekermann K; Humphries RK; Schnittger S; Kern W; Hiddemann W; Quintanilla-Martinez L; Bohlander SK; Feuring-Buske M; Buske C J Clin Invest; 2005 Aug; 115(8):2159-68. PubMed ID: 16025155 [TBL] [Abstract][Full Text] [Related]
12. AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia. Zhou F; Liu Y; Rohde C; Pauli C; Gerloff D; Köhn M; Misiak D; Bäumer N; Cui C; Göllner S; Oellerich T; Serve H; Garcia-Cuellar MP; Slany R; Maciejewski JP; Przychodzen B; Seliger B; Klein HU; Bartenhagen C; Berdel WE; Dugas M; Taketo MM; Farouq D; Schwartz S; Regev A; Hébert J; Sauvageau G; Pabst C; Hüttelmaier S; Müller-Tidow C Nat Cell Biol; 2017 Jul; 19(7):844-855. PubMed ID: 28650479 [TBL] [Abstract][Full Text] [Related]
13. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal. Schnoeder TM; Schwarzer A; Jayavelu AK; Hsu CJ; Kirkpatrick J; Döhner K; Perner F; Eifert T; Huber N; Arreba-Tutusaus P; Dolnik A; Assi SA; Nafria M; Jiang L; Dai YT; Chen Z; Chen SJ; Kellaway SG; Ptasinska A; Ng ES; Stanley EG; Elefanty AG; Buschbeck M; Bierhoff H; Brodt S; Matziolis G; Fischer KD; Hochhaus A; Chen CW; Heidenreich O; Mann M; Lane SW; Bullinger L; Ori A; von Eyss B; Bonifer C; Heidel FH Blood; 2022 Feb; 139(7):1080-1097. PubMed ID: 34695195 [TBL] [Abstract][Full Text] [Related]
14. The ETO domain is necessary for the developmental abnormalities associated with AML1-ETO expression in the hematopoietic stem cell compartment in vivo. de Guzman CG; Johnson A; Klug CA Blood Cells Mol Dis; 2003; 30(2):201-6. PubMed ID: 12732184 [TBL] [Abstract][Full Text] [Related]
15. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Dayyani F; Wang J; Yeh JR; Ahn EY; Tobey E; Zhang DE; Bernstein ID; Peterson RT; Sweetser DA Blood; 2008 Apr; 111(8):4338-47. PubMed ID: 18258796 [TBL] [Abstract][Full Text] [Related]
16. Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation. Zhou B; Ye H; Xing C; Liang B; Li H; Chen L; Huang X; Wu Y; Gao S J Cell Mol Med; 2019 Aug; 23(8):5246-5258. PubMed ID: 31119862 [TBL] [Abstract][Full Text] [Related]
17. The ordered acquisition of Class II and Class I mutations directs formation of human t(8;21) acute myelogenous leukemia stem cell. Shima T; Miyamoto T; Kikushige Y; Yuda J; Tochigi T; Yoshimoto G; Kato K; Takenaka K; Iwasaki H; Mizuno S; Goto N; Akashi K Exp Hematol; 2014 Nov; 42(11):955-65.e1-5. PubMed ID: 25101977 [TBL] [Abstract][Full Text] [Related]
18. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. Gao XN; Lin J; Ning QY; Gao L; Yao YS; Zhou JH; Li YH; Wang LL; Yu L PLoS One; 2013; 8(2):e55481. PubMed ID: 23390536 [TBL] [Abstract][Full Text] [Related]
19. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906 [TBL] [Abstract][Full Text] [Related]
20. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]